Skip to the content

Distribution and clinical significance of heparan sulfate proteoglycans in ovarian cancer

Davies, EJ, Blackhall, FH, Shanks, JH, David, G, McGown, AT, Swindell, R, Slade, RJ, Martin-Hirsch, P, Gallagher, JT and Jayson, GC 2004, 'Distribution and clinical significance of heparan sulfate proteoglycans in ovarian cancer' , Clinical Cancer Research, 10 (15) , pp. 5178-5186.

Full text not available from this repository. (Request a copy)

Abstract

Purpose: Heparan sulfate proteoglycans have been implicated in cancer cell growth, invasion, metastasis, and angiogenesis. This study was designed to compare their expression in normal ovary and ovarian tumors and then to examine their prognostic significance in ovarian cancer. Experimental Design: The expression of syndecan-1, -2, -3, and -4, glypican-1, and perlecan was assessed by immunohistochemistry in 147 biopsies that included normal ovary and benign, borderline, and malignant ovarian tumors. Clinical data, including tumor stage, performance status, treatment, and survival, were collected. Univariate and multivariate analyses were performed to evaluate prognostic significance. Results: The expression patterns of syndecan-1 and perlecan were altered in ovarian tumors compared with normal ovary. Syndecan-1 was not detected in normal ovary but was present in the epithelial and stromal cells of benign and borderline tumors and in ovarian adenocarcinomas. Perlecan expression was decreased in basement membranes that were disrupted by cancer cells but maintained in the basement membranes of blood vessels. Syndecan-2, -3, and -4, and glypican-1 were expressed in normal ovary and benign and malignant ovarian tumors. Stromal expression of syndecan-1 and glypican-1 were poor prognostic factors for survival in univariate analysis. Conclusion: We report for the first time distinct patterns of expression of cell surface and extracellular matrix heparan sulfate proteoglycans in normal ovary compared with ovarian tumors. These data reinforce the role of the tumor stroma in ovarian adenocarcinoma and suggest that stromal induction of syndecan-1 contributes to the pathogenesis of this malignancy.

Item Type: Article
Themes: Subjects / Themes > Q Science > Q Science (General)
Subjects / Themes > R Medicine > R Medicine (General)
Health and Wellbeing
Subjects outside of the University Themes
Schools: Colleges and Schools > College of Science & Technology
Colleges and Schools > College of Science & Technology > School of Environment and Life Sciences
Colleges and Schools > College of Science & Technology > School of Environment and Life Sciences > Biomedical Research Centre
Journal or Publication Title: Clinical Cancer Research
Publisher: American Association for Cancer Research
Refereed: Yes
ISSN: 10780432
Depositing User: H Kenna
Date Deposited: 08 Aug 2007 10:06
Last Modified: 20 Aug 2013 16:45
URI: http://usir.salford.ac.uk/id/eprint/157

Actions (login required)

Edit record (repository staff only)